Belite Bio, Inc (BLTE)
$158.87-1.36%Close
BUYRECOVERY · day 53
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $6.4B
- Avg volume
- 184.5K
- Beta
- -1.23
- P/E (TTM)
- -57.56
- Short % float
- 6.14%
- Days to cover
- 6.7
- SI change
- -13.7%
- 1W
- -2.66%
- 1M
- +3.59%
- 3M
- +15.71%
- YTD
- -0.25%
- vs SPY 1W
- -1.47%
- vs SPY 1M
- +0.27%
- vs SPY 3M
- +13.32%
- vs SPY YTD
- -12.01%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- CELCSELLCelcuity Inc.RECOVERYQ 29$90.79-2.93%
- DMRABUYGalecto, Inc.RECOVERYQ -3$30.31-1.65%
- ZURABUYZura Bio LimitedRECOVERYQ 13$6.30+7.69%
- XFORBUYX4 Pharmaceuticals, Inc.RECOVERYQ -12$4.05+0.25%
- MDGLSELLMadrigal Pharmaceuticals, Inc.RECOVERYQ 16$511.97-0.92%
- PHIOBUYPhio Pharmaceuticals Corp.RECOVERYQ 3$1.17-0.85%
- ARDXSELLArdelyx, Inc.CRISISQ 1$3.74-3.86%
- PASGSELLPassage Bio, Inc.RECOVERYQ -17$4.51+1.58%
- GLSIBUYGreenwich LifeSciences, Inc.RECOVERYQ 27$17.58+5.46%
- HROWSELLHarrow Health, Inc.RECOVERYQ 15$39.80-2.81%
- APUSSELLApimeds Pharmaceuticals US, IncCRISISQ -26$4.75-1.86%
- VNDABUYVanda Pharmaceuticals Inc.RECOVERYQ 13$5.33+0.95%
Industry peers
FMP comparable companies · ranked by market cap
- PRAXBUYPraxis Precision Medicines, Inc.$10.2BBULLQ 14$364.58-2.10%
- CRNXBUYCrinetics Pharmaceuticals, Inc.$9.0BBULLQ 26$84.69+0.11%
- MIRMSELLMirum Pharmaceuticals, Inc.$5.9BCRISISQ 38$97.07+0.43%
- LGNDSELLLigand Pharmaceuticals Incorporated$5.8BBEARQ 14$287.39-2.13%
- ACADBUYACADIA Pharmaceuticals Inc.$5.0BBULLQ 19$29.04+0.51%
- DYNBUYDyne Therapeutics, Inc.$4.9BBULLQ 8$25.98-0.42%
- VKTXSELLViking Therapeutics, Inc.$4.0BRECOVERYQ 23$34.36-1.95%
- ARQTSELLArcutis Biotherapeutics, Inc.$3.2BRECOVERYQ 10$25.35-1.20%
- SLNOSoleno Therapeutics, Inc.$2.8B$53.01
- ADMABUYADMA Biologics, Inc.$2.3BRECOVERYQ 8$9.76-2.95%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 14
- VALUE
- 5
- GROWTH
- 39
- GARP
- 0
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-12.3%
REV YoY-
ROE-20.6%
EPS YoY-
ROA-12.6%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-57.56
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B8.02
P/FCF-
EV/EBITDA-55.76
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO33.71
ND/EBITDA-
BETA-1.23
